Home
>
National Drug Code (NDC)
>
HYCAMTIN
HYCAMTIN - 0007-4201-01 - (topotecan hydrochloride)
Drug Information of HYCAMTIN
| Product NDC: | 0007-4201 |
| Proprietary Name: | HYCAMTIN |
| Non Proprietary Name: | topotecan hydrochloride |
| Active Ingredient(s): | 4 mg/4mL & nbsp; topotecan hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HYCAMTIN
| Product NDC: | 0007-4201 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020671 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960607 |
Package Information of HYCAMTIN
| Package NDC: | 0007-4201-01 |
| Package Description: | 1 VIAL in 1 PACKAGE (0007-4201-01) > 4 mL in 1 VIAL |
NDC Information of HYCAMTIN
| NDC Code | 0007-4201-01 |
| Proprietary Name | HYCAMTIN |
| Package Description | 1 VIAL in 1 PACKAGE (0007-4201-01) > 4 mL in 1 VIAL |
| Product NDC | 0007-4201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | topotecan hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19960607 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/4mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
